News

Originally posted on KMBC. To read full story and watch clip, visit here.

NORTH KANSAS CITY, Mo. —
Some communities across the country where COVID-19 cases are surging are running low on oxygen needed to treat patients. In Southern California, emergency responders have been asked to conserve supplies as hospitals run out of oxygen tanks.

Michael Carr is the owner of Pur Air Products based in North Kansas City which supplies medical oxygen to hospitals and healthcare providers in ten states. He says there is plenty of oxygen; the problem is a shortage of cylinders used to transport it.

“The concern is if we can’t get tanks to people then they start to stack up. They cannot leave the hospital; they may not be able to get into the hospital, but it slows down the process and it puts people at risk.”

At his warehouse, dozens of oxygen tanks are filled within minutes as staff work to keep up with demand.

“We generally keep three to four thousand tanks on hand ready to go in any given day,” said Carr. “I’ll tell you, that’s gone. Those tanks are in circulation. The concern is, if it continues can we meet that need?”

KMBC checked with hospitals across the metro. They say they have sufficient oxygen supplies. Carr hopes to help keep it that way.

“If our rates of infection don’t get higher then I think we can weather the storm. If we start spiraling out of control and people don’t watch what they are doing the yea, the real concern is that we will get into a situation where we are going to have true rationing of healthcare.”

Oxygen is critical for treating seriously ill patients, especially those suffering from COVID-19. The World Health Organization explained the urgency in addressing the global bottleneck in oxygen supplies in a recent bulletin.

“It has been estimated that around one in five people with COVID-19 suffers respiratory distress sufficient to require oxygen therapy,” says Dr Priyanka Relan, a COVID-19 clinical management expert at WHO. “Without that therapy, COVID-19 can be fatal.”

Oxygen makes up almost 21% of the earth’s atmosphere and is the third-most abundant element in the universe – but why is Liquid Oxygen (LOX) so beneficial to the rotorcraft industry?

Ahead of its debut at Helitech International, we spoke to Tina Masters, Marketing Director at Essex Industries to discuss the benefits of LOX in the rotorcraft industry and its key role on board for EMS Helicopters.

What are the benefits of liquid oxygen use in the rotorcraft industry?
Liquid oxygen (LOX) systems provide four primary benefits when used in the rotorcraft industry: Reduced weight, Increased space, safety and reductions in operating costs.

Reduced weight
Liquid oxygen increases in volume 860 times as it converts from a liquid to a gas. That means a smaller amount of LOX will produce a large volume of gas, reducing weight on the helicopter by eliminating the need for multiple cylinders without sacrificing capability.

Increased space
The same 1:860 liquid to gas ratio that reduces the cargo weight also increases the amount of available space on a helicopter. A single LOX converter eliminates the need for carrying multiple high-pressure cylinders, increasing the amount of usable space while supplying more gaseous oxygen.

Safety
LOX systems have operating pressures under 100 psi, as compared to high-pressure cylinders at 1800-2200 psi. This makes the units less volatile and therefore safer in the event of an accident.

Reductions in operating costs
Because of the increased capacity, LOX allows a team to fly more missions between refilling which reduces maintenance time spent servicing the system.

What are the typical uses for the technology?
The typical use for LOX is to provide breathable oxygen for life support. Essex Industries originally entered the market in 1963 with a line of LOX converters designed to supply oxygen for pilots and crew of military fighter/transport aircraft. We went on to develop a complete line of LOX equipment to support military medical operations, with products ranging from the OGL, a self-contained oxygen generator, to the BMOS, a portable medical oxygen system easily carried into the field.

The technology developed for military LOX systems led to similar advancements in the commercial medevac marketplace. LOX systems are found on both fixed wing and rotary medevac platforms, where they provide direct support for patients and run oxygen-powered devices, such as ventilators.

What are the opportunities / challenges for uptake in the European market?

We see great potential for LOX in the European HEMS market. Recognising that every market has its own characteristics, the primary benefits found in the U.S. market of more oxygen with reduced weight and increased space have application worldwide. As with any market, the challenge is always to learn as much as we can about the customers’ requirements and what is necessary to transfer the technology.

What has delayed the uptake of liquid oxygen equipment to date?
In our opinion, it is a matter of awareness of its availability and the related logistics in the European market—not of the technology, itself. With European HEMS operators attending U.S. tradeshows where LOX is being displayed, awareness in Europe is on the rise. In fact, it is new interest from operators in Europe that led Essex to exhibit at Helitech this year. It will also take some time to develop the first EASA-approved STC for the installation of LOX on a helicopter, in Europe, despite LOX being widely approved by the FAA for use in the U.S. market.

This article was written by helitech international. To continue reading this article visit their website here.

Coherent Market Insights has announced the addition of the “Global Medical Oxygen Systems Market Size Status and Forecast 2026”, The report classifies the global Medical Oxygen Systems Market in a precise manner to offer detailed insights about the aspects responsible for augmenting as well as restraining market growth.

This report studies the global Medical Oxygen Systems Speaker market, analyzes and researches the Medical Oxygen Systems Speaker development status and forecast in North America, Europe, Asia Pacific, Latin America and Rest of the World. This report focuses on the top players in global market, like Cryofab, Respironics, Medtronic, Atlas Copco, Terumo Medical, Keen Compressed Gas, Inogen, GF Health Products, and Invacare.

Medical oxygen systems are prescribed to the patients as a part of oxygen therapy to the patient population suffering from chronic or acute respiratory malfunctions and disorders. Oxygen therapy is also given to children to curb the diseases including cystic fibrosis, congenital heart diseases and severe asthma. The medical oxygen systems provides life support especially to the aging population suffering from respiratory disorders. The other benefits provided by the medical oxygen systems include reduction in fatigue, improving sleeping patterns in sleep apnea cases and easing tightness of breathe. The emergency supply system, redundant tank system and portable systems are the commonly used systems in the healthcare facilities to ensure continuous oxygen supply.

Medical oxygen systems are equipment ranging in various sizes containing oxygen. The stored oxygen is obtained in compressed, concentrated or liquid form. Medical oxygen systems are the integral factors supporting life systems in the healthcare facilities. The supplemental oxygen is delivered to the patient via oxygen mask. These systems are used to aid cardiovascular stability, restore tissue oxygen tension by improving oxygen availability, provide basis for the modern anesthetic techniques.

The medical oxygen systems market is expected to gain steady traction in the foreseeable future, as the devices finds application across a wide number of healthcare facilities. Manufacturers are focused on producing ultra-lightweight cylinders. For instance, the ultra-lightweight oxygen cylinders are portable devices manufactured by Luxfer and Boschi Italy, offering cost effective oxygen cylinders that are 30% lighter than conventional cylinders. Patient-driven system design and embedded valve regulatory technology by developing light weight portable oxygen systems.

Market Growth

The increasing prevalence of chronic obstructive pulmonary diseases is the major factor driving the global medical oxygen systems market. According to the Department of Economic and Social Affairs Population Division 2013, the global geriatric population is set to reach over 2 billion by 2050 from 800 million in 2012. The geriatric population is at a higher risk of acquiring respiratory diseases like fibrosis, pulmonary hypertension and asthma. Additionally, the rising preference of interventional cardiologists for nonsurgical procedures, technological innovations and significant growth of the portable oxygen concentrators is expected to drive the growth of the medical oxygen systems market in North America and Western Europe over the forecast period. However, expensive product costs and stringent FDA regulations for the approval of new systems are the restraining factors for the global medical oxygen systems market.

The growing consumer awareness for oxygen therapy devices, investments by manufacturers for the production of homecare products and adoption of innovative technologies is expected to rise the global medical oxygen systems market. According to the Centers of Disease Control and Prevention statistics in 2017, around 1.9 million physician office and outpatient visits are recorded with the people suffering from heart disease in the U.S. North America is expected to dominate the global medical oxygen systems market owing to increasing prevalence of COPD, changing consumer lifestyles, increased government expenditures for research and development on cost-effective oxygen devices. The innovative portable and ultra-light oxygen concentrator separates nitrogen and oxygen from the environmental air providing 95% pure oxygen to patients. Portable oxygen concentrators are largely used by travelers and mountaineers in regions of inadequate oxygen supply, thereby fueling growth of the medical oxygen systems market.

This article was written by openPR Worldwide Public Relations. To continue reading this article visit their website here.

Oxygen therapy is a form treatment provided to a patient in a medical condition, which can help to get enough oxygen. This equipment is used for the treatment of various diseases such as COPD, asthma, and others where there is deficient supply of oxygen to the patient. Increase in prevalence of acute and chronic diseases results into critical need for the oxygen therapy equipment.

The growth of the oxygen therapy equipment is driven by various factors such as increase in tobacco smoking and rise in prevalence of respiratory disorders, increase in preference for standalone oxygen therapy equipment to portable ones, and continuous technological advancements in the area of oxygen therapy. However, stringent regulatory guidelines that may cause delay in the product approval of oxygen therapy products hampers the market growth. Rise in patient pool suffering from respiratory diseases is expected to pro ide opportunities for the market growth.

Get Sample PDF Brochure at : www.alliedmarketresearch.com/request-toc-and-sample/3662

The report segments the oxygen therapy equipment market on the basis of product, portability, application, and geography. Based on product, the market for oxygen therapy equipment is categorized into oxygen source equipment and oxygen delivery devices. The oxygen source equipment is sub segmented into oxygen concentrators, liquid oxygen devices, and oxygen cylinders. The oxygen delivery devices segment is further sub segmented into oxygen masks, nasal cannulas, enturi masks, non-rebreather masks, bag- al e masks, and other oxygen delivery devices. Based on portability, the market is classified into standalone and portable devices. By application, it is categorized into COPD, asthma, cystic fibrosis, respiratory distress syndrome, pneumonia, and other diseases. Geographical breakdown and deep analysis of each of the aforesaid segments is included for North America, Europe, Asia-Pacific, and LAMEA.

Comprehensive competitive analysis and profiles of major market players such as Koninklijke Philips N. V., Linde Healthcare, Chart Industries, Inc., In acare Corporation, Becton, Dickinson and Company, Smiths Medical, Drgerwerk AG & Co. KGaA, Teleflex Incorporated, Fisher & Paykel Healthcare Corporation Limited, Taiyo Nippon Sanso Corporation, and Inogen, Inc. are provided in this report.

Key Benefits

• This report pro ides an extensive analysis of the current and emerging market trends and dynamics in the global oxygen therapy equipment market.
• In-depth analysis has been done in this report by constructing market estimations for the key market segments between 2017 and 2023.
• This report entails the detailed quantitative analysis of the current trends and future estimations from 2017 to 2023, which assists to identify the prevailing market opportunities.
• Comprehensive analysis of factors that drive and restrict the growth of the market is provided.
• Exhaustive analysis of the global market by product helps to understand the types of oxygen therapy equipment that are currently being used along with the variants that are expected to gain prominence in the future.
• An in-depth analysis of current research and clinical developments within the market is provided with key factors that help to understand the behavior of the market

This article was written by openPR Worldwide Public Relations. To continue reading this article visit their website here.

While respiratory providers typically focus on Medicare’s 36-month rental, there is also a short-term rental market for oxygen equipment. Entering either business requires solid planning.

When Is A Rental Not A Rental?

As respiratory providers know, the oxygen business splits into two main categories: One is called rental, but that really describes the payment arrangement in which Medicare pays a provider a monthly fee for three years to provide equipment for long-term oxygen therapy (LTOT) patients. After the 36 months, the patient owns the device, but the provider must continue to provide warranty protections and service for another two years. The other model is true rental, in which companies – usually specialized providers – offer true equipment rental and support for patients with short-term needs.

The first group is long-term oxygen therapy patients, primarily chronic pulmonary (COPD) patients. They are likely to use oxygen supplements an average of 15 hours a day. Much of that is at home, where they may use a tank system as a primary source but portable oxygen concentrators (POCs) are expanding patient horizons with devices that are compact, lightweight and less intrusive.

The second group overlaps the first: it might be a home oxygen patient who just needs a POC or other arrangement for an event or trip, or as support for another treatment.

Who Are The Short-Term Renters?

“Short-term POC patients are hospice patients who want to go to a wedding or graduation, someone who is traveling across the country,” says Elliott Campbell, senior vice president of Trace Medical. The company’s main business is ventilators, but, “We were getting people who say, ‘I need a POC, but I don’t need it for long.’” Campbell says. That launched Trace’s POC rental business, “for people where it does not make sense to buy.”

For those patients, companies such as Trace and VGM Freedom Link work with DMEs to give patients the service they need, without encumbering the DME with long-term oxygen support obligations. In this scenario, the DME is mainly a middleman providing a referral as a service, a facilitator cultivating the broader customer relationship.

“When we get a call directly from a patient, we refer them to a DME. We rent [equipment] to the DME and they rent it to the patient. Trace does not deal with patient billing,” Campbell says. Trace has a relationship with an authorized service center that does all of the maintenance, repair and service on equipment the company rents. True rental is also largely a cash business with few, if any, reimbursement options.

Either way, oxygen is a drug, so providers need the correct licensing to provide it. That means providers need to have the right resources and knowledge.

This article was written by HME Business. To continue reading the article, visit their website here.

A recent study titled Global Oxygen Therapy Device Market  2018 report by APEX MARKET RESEARCH provides fresh insights into the market including competitive landscape, Oxygen Therapy Device manufacturing technology, demand drivers, top players and technological foundations.

Oxygen therapy, also known as supplemental oxygen, is the use of oxygen as a medical treatment. This can include for low blood oxygen, carbon monoxide toxicity, cluster headaches, and to maintain enough oxygen while inhaled anesthetics are given. Long term oxygen is often useful in people with chronically low oxygen such as from severe COPD or cystic fibrosis. Oxygen can be given in a number of ways including nasal cannula, face mask, and inside a hyperbaric chamber.

The use of oxygen in medicine became common around 1917. It is on the World Health Organization’s List of Essential Medicines, the most effective and safe medicines needed in a health system. The cost of home oxygen is about 150 USD a month in Brazil and 400 USD a month in the United States. Home oxygen can be provided either by oxygen tanks or an oxygen concentrator. Oxygen is believed to be the most common treatment given in hospitals in the developed world.
The global Oxygen Therapy Device market was xx million US$ in 2017 and is expected to xx million US$ by the end of 2025, growing at a CAGR of xx% between 2018 and 2025.

This article was written by News Zak. To continue reading the article, visit their website here.